Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
NEW YORK and MAINZ, GERMANY, August 22, 2024 - Pfizer Inc. ( NYSE: PFE, "Pfizer" ) and BioNTech SE ( Nasdaq: BNTX, "BioNTech" ) today announced that the U.S. Food and Drug Administration ( "FDA" ) has approved the supplemental Biologics License Application for individuals 12 years of age and ...
| Ticker |
Sentiment |
Impact |
|
META
|
Somewhat Bullish
|
1 %
|
|
ADCT
|
Neutral
|
1 %
|
|
FOSUF
|
Neutral
|
1 %
|
|
GMAB
|
Neutral
|
1 %
|
|
PFE
|
Neutral
|
33 %
|
|
BNTX
|
Neutral
|
33 %
|
